GO:0035254 glutamate receptor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035254 (glutamate receptor binding) is a molecular function defined as binding to a glutamate receptor, a core interaction that underlies glutamatergic signaling.
• Glutamate receptor binding is mediated by ligand-binding domains (LBDs) that undergo conformational closure upon agonist binding, a mechanism conserved from mammals to plants.
• Glycosylation of ionotropic glutamate receptors influences ligand binding, function, and trafficking, making it a key regulatory layer.
• Altered glutamate receptor binding is associated with aging and neurodegenerative conditions, as shown by increased [3H]glutamate binding in aged rats.
• Delta-type glutamate receptors (GluD) are ligand-gated ion channels, expanding the functional repertoire of glutamate receptor binding beyond classical AMPA/NMDA/Kainate receptors.
• Studying glutamate receptor binding requires integrated structural, biochemical, and genetic approaches, including CRISPR-based models and high-throughput screening.
Description
Glutamate receptor binding (GO:0035254) is a molecular function that describes the physical interaction between a protein or other molecule and a glutamate receptor. This binding event is the first step in glutamatergic neurotransmission and is essential for converting chemical signals into cellular responses. The term encompasses interactions with both ionotropic and metabotropic glutamate receptors, as well as plant glutamate receptor-like channels. Understanding glutamate receptor binding is fundamental for neurobiologists, pharmacologists, and structural biologists because it directly controls synaptic plasticity, excitability, and gene expression. Dysregulation of this binding is implicated in aging, neurodegeneration, and neurological disorders. Moreover, the discovery that delta-type glutamate receptors function as ligand-gated ion channels highlights the evolving complexity of this binding function. Researchers studying GO:0035254 aim to define the molecular determinants of receptor-ligand recognition, the kinetic and structural consequences of binding, and how these events can be modulated for therapeutic benefit.
glutamate receptor binding At A Glance
| GO ID | GO:0035254 |
|---|---|
| GO term | glutamate receptor binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a glutamate receptor, enabling signal transduction and modulation |
| Definition source | QuickGO |
| Related receptors | Ionotropic (AMPA, NMDA, kainate, delta) and metabotropic glutamate receptors, plant GLRs |
| Key domains | Ligand-binding domain (LBD), amino-terminal domain (ATD) |
| Regulatory feature | Glycosylation influences ligand binding and trafficking |
What Is GO:0035254?
In our own words, GO:0035254 (glutamate receptor binding) is the molecular function of selectively and non-covalently interacting with a glutamate receptor. This includes binding to any protein classified as a glutamate receptor, such as ionotropic AMPA, NMDA, kainate, and delta receptors, as well as metabotropic glutamate receptors and plant glutamate receptor-like channels. The binding may occur at the orthosteric ligand-binding domain, at allosteric sites, or at auxiliary subunit interfaces, and it is a prerequisite for receptor activation, modulation, or trafficking.
Why Is glutamate receptor binding Important in Cell Biology?
Glutamate receptor binding is important because it is the molecular trigger for fast excitatory neurotransmission in the mammalian brain and for glutamate sensing in plants. This binding event controls synaptic strength, plasticity, learning, and memory, and its dysfunction is linked to neurological and psychiatric disorders. In addition, the binding properties of glutamate receptors determine the efficacy of therapeutic drugs targeting these receptors, making GO:0035254 a central node for drug discovery and structural biology.
• Controls the initiation of excitatory synaptic transmission in the central nervous system.
• Underlies synaptic plasticity mechanisms such as long-term potentiation and depression.
• Is altered in aging, as shown by increased [3H]glutamate receptor binding in aged rats.
• Influences receptor trafficking and surface expression via glycosylation-dependent mechanisms.
• Represents a target for neuroprotective and antipsychotic drug development.
• Is conserved in plants, where GLR3.2 ligand-binding domain structure informs plant glutamate sensing.
• Delta-type glutamate receptors are ligand-gated ion channels, expanding the scope of glutamate receptor binding.
• Provides a mechanistic basis for understanding excitotoxicity and neurodegeneration.
• Enables high-throughput screening for modulators of glutamatergic signaling.
• Facilitates comparative studies of receptor evolution across insects and mammals.
Molecular Mechanism of glutamate receptor binding
Ligand recognition and binding domain closure
In simple terms: When glutamate or a similar molecule docks into the receptor, the receptor's binding pocket closes around it like a clamshell.
Glutamate receptor binding begins with the recognition of the ligand by the extracellular ligand-binding domain (LBD). Structural studies of the Arabidopsis glutamate receptor-like channel GLR3.2 LBD revealed a bilobed architecture that undergoes conformational closure upon ligand binding. Similarly, in ionotropic glutamate receptors, agonist binding induces closure of the LBD, which is a critical step for receptor activation. D-Serine potently drives LBD closure in the delta-type receptor GluD2, demonstrating that different ligands can differentially stabilize closed states. This closure is the primary determinant of binding affinity and efficacy.
Conformational coupling and channel gating
In simple terms: The closing of the binding pocket pulls on the rest of the receptor, opening a channel that lets ions flow.
Following LBD closure, the conformational change is transmitted to the transmembrane domains, leading to opening of the ion channel pore in ionotropic receptors. This coupling is allosteric and involves interactions between the LBD and the pore-forming domains. Delta-type glutamate receptors, once considered non-conducting, have been shown to be ligand-gated ion channels, indicating that similar gating mechanisms apply. The efficiency of coupling determines the receptor's response to glutamate and is modulated by auxiliary subunits.
Role of glycosylation in binding and trafficking
In simple terms: Sugar molecules attached to the receptor can affect how well it binds glutamate and how it moves to the cell surface.
Glycosylation of ionotropic glutamate receptors is a key post-translational modification that influences ligand binding, receptor function, and trafficking to the plasma membrane. Specific N-glycosylation sites can alter the conformation of the LBD and affect agonist affinity. This regulatory layer adds complexity to glutamate receptor binding and is important for understanding receptor biogenesis and synaptic targeting.
Pharmacological and evolutionary diversity
In simple terms: Different animals and plants have slightly different glutamate receptors, but the basic binding mechanism is similar.
Glutamate receptor binding is conserved across evolution, from insects to mammals, as demonstrated by early binding studies. In plants, glutamate receptor-like channels such as GLR3.2 bind glutamate and related amino acids, and their LBD structure provides insights into ligand specificity. This diversity allows researchers to use comparative approaches to identify conserved and divergent features of glutamate receptor binding.
Modulation by auxiliary proteins and allosteric ligands
In simple terms: Other proteins and small molecules can change how tightly glutamate binds to its receptor.
Auxiliary subunits and allosteric modulators can influence glutamate receptor binding by altering the conformation or stability of the LBD. For example, the binding of D-serine to GluD2 LBD drives closure and affects receptor function. Additionally, the binding of glutamate receptor-interacting proteins can regulate receptor localization and downstream signaling. Understanding these modulatory mechanisms is essential for developing drugs that selectively target specific receptor subtypes.
Key Genes Involved in GO:0035254 glutamate receptor binding
The following genes encode proteins that either bind to glutamate receptors or are themselves glutamate receptors, and they are central to research on GO:0035254.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIA1 | AMPA receptor subunit GluA1; binds glutamate and mediates fast synaptic transmission | Studies of LBD closure and ion channel gating |
| GRIA2 | AMPA receptor subunit GluA2; controls calcium permeability and trafficking | Glycosylation and trafficking studies |
| GRIN1 | NMDA receptor subunit GluN1; obligatory subunit for NMDA receptors | Binding affinity and allosteric modulation |
| GRIN2A | NMDA receptor subunit GluN2A; modulates channel properties | Pharmacological and structural studies |
| GRIN2B | NMDA receptor subunit GluN2B; involved in synaptic plasticity | Disease models and drug discovery |
| GRIK1 | Kainate receptor subunit GluK1; binds glutamate | Comparative binding studies |
| GRIK2 | Kainate receptor subunit GluK2; mediates excitatory transmission | Receptor gating and trafficking |
| GRID1 | Delta-type receptor subunit GluD1; ligand-gated ion channel | Novel gating mechanisms |
| GRID2 | Delta-type receptor subunit GluD2; binds D-serine and glutamate | LBD closure and channel function |
| GRM1 | Metabotropic glutamate receptor 1; binds glutamate and activates Gq | Allosteric modulation and signaling |
| GRM2 | Metabotropic glutamate receptor 2; Gi-coupled | Presynaptic regulation |
| GRM5 | Metabotropic glutamate receptor 5; modulates synaptic plasticity | Drug target for neurological disorders |
| GLR3.2 | Plant glutamate receptor-like channel; binds glutamate | Structural basis of ligand binding in plants |
| GRIP1 | Glutamate receptor-interacting protein 1; binds AMPA receptors | Receptor anchoring and trafficking |
| GRIP2 | Glutamate receptor-interacting protein 2; binds AMPA receptors | Synaptic targeting |
| PSD-95 | Postsynaptic density protein 95; binds NMDA receptors | Scaffolding and signaling |
| SAP102 | Synapse-associated protein 102; binds NMDA receptors | Receptor clustering |
How Is glutamate receptor binding Regulated?
Glutamate receptor binding is regulated at multiple levels. Glycosylation of ionotropic glutamate receptors modulates ligand binding affinity and receptor trafficking. Phosphorylation by kinases such as PKA and PKC can alter receptor surface expression and binding properties. Auxiliary subunits, such as TARPs for AMPA receptors and neto proteins for kainate receptors, modify binding kinetics and channel gating. In addition, allosteric modulators can enhance or inhibit binding, providing a means for pharmacological regulation. Aging is associated with increased [3H]glutamate receptor binding in certain brain regions, suggesting that binding is subject to age-related regulation.
glutamate receptor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRIN2A | Epileptic encephalopathy, intellectual disability | Knock-in mouse with patient mutation; iPSC-derived neurons |
| GRIN2B | Autism spectrum disorder, schizophrenia | Conditional knockout mouse; overexpression in cell lines |
| GRIA1 | Epilepsy, cognitive impairment | Point mutation knock-in; electrophysiology |
| GRM5 | Fragile X syndrome, anxiety | Knockout mouse; allosteric modulator testing |
| GRID2 | Cerebellar ataxia, neurodegeneration | Spontaneous mouse mutant; CRISPR knock-in |
Neurodegenerative disorders
Altered glutamate receptor binding contributes to excitotoxicity in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Overactivation of NMDA receptors due to excessive glutamate binding leads to calcium influx and neuronal death. In aged rats, increased [3H]glutamate receptor binding has been observed, which may predispose to excitotoxic injury.
Epilepsy and seizure disorders
Mutations in glutamate receptor genes that affect ligand binding can cause hyperexcitability and epilepsy. For example, mutations in GRIN2A and GRIN2B alter NMDA receptor function and are linked to epileptic encephalopathies. Understanding the binding defects helps in designing targeted therapies.
Psychiatric disorders
Dysregulation of glutamate receptor binding is implicated in schizophrenia, depression, and anxiety. Metabotropic glutamate receptors, particularly mGluR2 and mGluR5, are targets for antipsychotic and antidepressant drug development. Delta-type receptors may also play a role in psychiatric conditions.
Plant biology and agriculture
In plants, glutamate receptor-like channels are involved in stress responses and calcium signaling. The structure of GLR3.2 LBD provides a basis for understanding how plants sense glutamate and could inform crop improvement.
From glutamate receptor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific point mutation alter ligand binding affinity? | CRISPR point-mutation knock-in cell line (e.g., HEK293T) expressing mutant receptor |
| What is the effect of gene knockout on synaptic transmission? | CRISPR knockout mouse or primary neuronal cultures |
| How does a disease-associated mutation affect receptor trafficking? | Knock-in of mutant allele in iPSC-derived neurons |
| Can a candidate protein directly bind to glutamate receptors? | Overexpression of tagged protein followed by co-immunoprecipitation |
| What is the role of glycosylation in binding? | Site-directed mutagenesis of N-glycosylation sites; lectin binding assays |
| How does an allosteric modulator affect binding? | Overexpression of receptor in cell lines; radioligand binding assays |
How to Study the glutamate receptor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Binding affinity (Kd) and receptor density (Bmax) | Characterizing receptor pharmacology |
| X-ray crystallography | Three-dimensional structure of ligand-binding domain | Understanding ligand recognition |
| Cryo-EM | Structure of full-length receptor in different states | Visualizing gating mechanisms |
| Patch-clamp electrophysiology | Ion channel currents in response to ligands | Functional validation of binding |
| FRET/BRET | Real-time binding kinetics and conformational changes | High-throughput screening |
| Site-directed mutagenesis | Role of specific residues in binding | Mapping binding pocket |
| Glycosylation analysis | Effect of glycans on binding and trafficking | Post-translational regulation |
| Co-immunoprecipitation | Protein-protein interactions with receptors | Identifying binding partners |
Radioligand binding assays
Radioligand binding assays using tritiated glutamate or selective agonists are classic methods to quantify glutamate receptor binding affinity and density. These assays have been used to demonstrate increased [3H]glutamate binding in aged rats and to compare binding properties across species.
Structural biology (X-ray crystallography and cryo-EM)
Structural determination of ligand-binding domains provides atomic-level insights into glutamate receptor binding. The crystal structure of Arabidopsis GLR3.2 LBD revealed the closed conformation upon ligand binding. Cryo-EM structures of delta-type receptors have elucidated their ligand-gated ion channel architecture.
Electrophysiology
Patch-clamp and two-electrode voltage-clamp recordings measure the functional consequences of glutamate receptor binding, such as ion channel opening and desensitization. These techniques are essential for linking binding events to receptor gating.
Fluorescence-based binding assays
Fluorescence resonance energy transfer (FRET) and fluorescent ligand-based assays allow real-time monitoring of glutamate receptor binding in live cells. These methods are useful for high-throughput screening of compounds that modulate binding.
How CRISPR Can Be Used to Study GO:0035254 glutamate receptor binding
Knockout
CRISPR knockout of genes encoding glutamate receptors or their binding partners can abolish specific binding interactions, allowing researchers to study the contribution of individual proteins to synaptic transmission and behavior. For example, knocking out GRIN1 in mice results in loss of NMDA receptor function and severe neurological phenotypes.
Point Mutation
CRISPR point mutation introduces precise amino acid substitutions in ligand-binding domains to test their role in glutamate binding. This approach can replicate human disease mutations, such as those in GRIN2A, and assess their impact on binding affinity and channel gating.
Knock-in
CRISPR knock-in can insert reporter tags or disease-associated alleles into endogenous loci. Tagged knock-in of glutamate receptor subunits enables visualization of receptor trafficking and binding in live cells. Knock-in of mutant alleles in iPSCs provides a platform for studying patient-specific binding defects.
Overexpression
CRISPR-mediated overexpression (e.g., via CRISPR activation) or traditional cDNA overexpression can increase levels of glutamate receptors or binding proteins to study binding kinetics and downstream signaling. Overexpression in heterologous systems is widely used for structural and pharmacological studies.
How EDITGENE Supports glutamate receptor binding Research
Researchers studying glutamate receptor binding-related genes often need to determine whether a candidate gene is causally involved in receptor function, synaptic transmission, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for glutamate receptor binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CAMK2A Knockout HEK293 Cell Line | EDJ-KQ282 | Human | 815 | Details Get a Quote |
| RASGRF1 Knockout HEK293 Cell Line | EDJ-KQ745 | Human | 5923 | Details Get a Quote |
| GRIA1 Knockout HEK293 Cell Line | EDJ-KQ1815 | Human | 2890 | Details Get a Quote |
| HIP1 Knockout HEK293 Cell Line | EDJ-KQ4867 | Human | 3092 | Details Get a Quote |
| PTPN4 Knockout HEK293 Cell Line | EDJ-KQ5597 | Human | 5775 | Details Get a Quote |
| AKAP5 Knockout HEK293 Cell Line | EDJ-KQ6613 | Human | 9495 | Details Get a Quote |
| SYNDIG1 Knockout HEK293 Cell Line | EDJ-KQ15580 | Human | 79953 | Details Get a Quote |
| RASGRF1 Knockout HCT 116 Cell Line | EDJ-KQ19393 | Human | 5923 | Details Get a Quote |
| HIP1 Knockout A-549 Cell Line | EDJ-KQ27645 | Human | 3092 | Details Get a Quote |
| HIP1 Knockout HCT 116 Cell Line | EDJ-KQ27646 | Human | 3092 | Details Get a Quote |
| HIP1 Knockout HeLa Cell Line | EDJ-KQ27647 | Human | 3092 | Details Get a Quote |
| PTPN4 Knockout A-549 Cell Line | EDJ-KQ28875 | Human | 5775 | Details Get a Quote |
| PTPN4 Knockout HCT 116 Cell Line | EDJ-KQ28876 | Human | 5775 | Details Get a Quote |
| PTPN4 Knockout HeLa Cell Line | EDJ-KQ28877 | Human | 5775 | Details Get a Quote |
| AKAP5 Knockout HeLa Cell Line | EDJ-KQ29509 | Human | 9495 | Details Get a Quote |
Displaying Records 1 To 15 Of 29 Records
Frequently Asked Questions About glutamate receptor binding
What is GO:0035254?
GO:0035254 is the Gene Ontology molecular function term for glutamate receptor binding, defined as binding to a glutamate receptor.
What genes are involved in glutamate receptor binding?
Genes encoding glutamate receptors (e.g., GRIA1, GRIN1, GRM1) and their interacting proteins (e.g., GRIP1, PSD-95) are involved.
How does glutamate bind to its receptor?
Glutamate binds to the ligand-binding domain, inducing closure of the domain and subsequent channel gating.
What is the role of glycosylation in glutamate receptor binding?
Glycosylation modulates ligand binding affinity, receptor function, and trafficking to the cell surface.
Is glutamate receptor binding altered in aging?
Yes, studies in aged rats show increased [3H]glutamate receptor binding in certain brain regions.
What are delta-type glutamate receptors?
Delta-type glutamate receptors (GluD1, GluD2) are ligand-gated ion channels that bind D-serine and glutamate, as shown by structural and functional studies.
How can I study glutamate receptor binding in the lab?
Common methods include radioligand binding assays, electrophysiology, structural biology, and fluorescence-based assays.
What diseases are linked to glutamate receptor binding?
Neurodegenerative disorders, epilepsy, and psychiatric disorders are associated with altered glutamate receptor binding.
Can CRISPR be used to study glutamate receptor binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of binding mechanisms.
What services does EDITGENE offer for glutamate receptor research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to glutamate receptor binding studies.
Conclusion
Glutamate receptor binding (GO:0035254) is a fundamental molecular function that governs excitatory neurotransmission and glutamate sensing across species. Its mechanisms involve ligand-induced conformational changes, allosteric modulation, and post-translational regulation, with profound implications for neurological disease and drug discovery. Leveraging CRISPR-based models and advanced screening technologies will continue to unravel the complexities of this binding event and translate findings into therapeutic strategies.
References
- 1. Briley PA et al.. 1981. Glutamate receptor binding in insects and mammals.. Mol Cell Biochem 39:347-56 PMID: 6118825
- 2. Erreger K et al.. 2004. Glutamate receptor gating.. Crit Rev Neurobiol 16(3):187-224 PMID: 15701057
- 3. Wang H et al.. 2025. Delta-type glutamate receptors are ligand-gated ion channels.. Nature 647(8091):1063-1071 PMID: 40957579
- 4. Gangwar SP et al.. 2021. Structure of the Arabidopsis Glutamate Receptor-like Channel GLR3.2 Ligand-Binding Domain.. Structure 29(2):161-169.e4 PMID: 33027636
- 5. Westbrook GL. 1994. Glutamate receptor update.. Curr Opin Neurobiol 4(3):337-46 PMID: 7522676
- 6. Standley S et al.. 2000. The role of glycosylation in ionotropic glutamate receptor ligand binding, function, and trafficking.. Cell Mol Life Sci 57(11):1508-16 PMID: 11092445
- 7. Baudry M et al.. 1981. Increased [3H]glutamate receptor binding in aged rats.. Brain Res 223(1):195-8 PMID: 6269700
- 8. Chin AC et al.. 2020. D-Serine Potently Drives Ligand-Binding Domain Closure in the Ionotropic Glutamate Receptor GluD2.. Structure 28(10):1168-1178.e2 PMID: 32735769
